Copper regulation of hypoxia-inducible factor-1 activity
After the crackdown, patients on compounded tirzepatide faced three options: (1) transition to branded Zepbound at $1,000+ per month out-of-pocket, (2) switch to compounded semaglutide, which remained legal because Ozempic and Wegovy were still on the FDA shortage list through Q1 2025, or (3) discontinue GLP-1 therapy entirely
This therapy can help support faster recovery, boost energy levels, and move you toward your health goals, tailored to each individuals needs
Gastric Emptying and Appetite Regulation GLP-1 slows gastric emptying, which prolongs the digestive process and leads to a slower and more gradual absorption of nutrients
For millions of people, the needle was the barrier
The main difference between Zepbound and Mounjaro isnt in the medication itself